FATE THERAPEUTICS INC Repayments of Convertible Debt
FATE THERAPEUTICS INC (FATE) reported Repayments of Convertible Debt of $1.68 million for the 80-month period ending 2013-12-31, per its 10-K filed 2014-03-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2016-03-03
- FATE THERAPEUTICS INC repayments of convertible debt for fiscal 2013 was $1.68M.
| Period end | Repayments of Convertible Debt 0 month | Repayments of Convertible Debt | Repayments of Convertible Debt 12 month | Repayments of Convertible Debt 80 month |
|---|---|---|---|---|
| 2013-12-31 | $1.68M 10-K · filed 2016-03-03 | $1.68M 10-K · filed 2014-03-17 | ||
| 2013-10-04 | $1.70M 10-Q · filed 2014-11-12 | $1.70M 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |